Revolade

Medicinal product

(Invented) name

Revolade

Active substance (s)

Eltrombopagas

Strength

25 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B02BX05, Eltrombopag

Marketing authorisation holder

Novartis Europharm Ltd., Airija

Date of authorisation

2010-03-11

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Eltrombopagas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
40068	53805	1053805	lizdinė plokštelė	N14		Receptinis	EU/1/10/612/001	Netiekiama	-	-	No	-	-
40069	53806	1053806	lizdinė plokštelė	N28		Receptinis	EU/1/10/612/002	Tiekiama	-	-	No	-	-
40070	53807	1053807	lizdinė plokštelė	N84 (3x28)		Receptinis	EU/1/10/612/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2010-03-11	Registruotas